Brazil Cardiac Surgery Instruments Market Report 2022 to 2030

Brazil Cardiac Surgery Instruments Market Analysis

$ 3999

Brazil's Cardiac Surgery Instruments Market is expected to witness growth from $52 Mn in 2022 to $93 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-30. Heart diseases like coronary artery disease and heart failure are very common in Brazil. Due to the rise in cardiac surgeries as a result, there is an increasing need for the tools and instruments used in these operations. The market is segmented by type, application, and end user. Some key players in this market include: Nipro Medical do Brasil Ltda, Arthrocare do Brasil Ltda, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10BRMD004 CATEGORY: Medical Devices GEOGRAPHY: Brazil AUTHOR: Jigyasu Bhandari

Buy Now

Brazil Cardiac Surgery Instruments Healthcare Market Executive Analysis

Brazil's Cardiac Surgery Instruments Market is expected to witness growth from $52 Mn in 2022 to $93 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-30.. Brazil's current health expenditures rose from 9.46% in 2018 to 9.59% in 2019. (as a percentage of GDP). By 2040, Brazil's health expenditures will account for 12.6% of its GDP, with space for expansion in areas like basic care, hospital care, medications, long-term care, and administration. Brazil has a male life expectancy of 72.5 years and a female life expectancy of 79.5 years. Brazil's population is growing by 0.7% annually.

In Brazil, Coronary heart disease, which affects over 100,000 individuals a year, is the main cause of death there. The infectious illness Chagas disease, which can lead to heart disease, is very common in Brazil. Between 1.9 and 4.6 million people in Brazil are afflicted by the illness, which claims about 7,000 lives annually. The sickness known as rheumatic heart disease, which is preventable, is brought on by untreated streptococcal infections. In Brazil, Coronary heart disease, which affects over 100,000 individuals a year, is the main cause of death there. The infectious illness Chagas disease, which can lead to heart disease, is very common in Brazil. Between 1.9 and 4.6 million people in Brazil are afflicted by the illness, which claims about 7,000 lives annually. The sickness known as rheumatic heart disease, which is preventable, is brought on by untreated streptococcal infections.

Brazil Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

In Brazil, Coronary artery disease and heart failure are very common cardiac diseases. As a result of the increase in cardiac surgeries, there is an increasing need for the tools used in these procedures. As more hospitals and organizations, particularly in the private sector, open, the Brazilian healthcare system expands. Equipment for cardiac surgery is now more necessary than ever because of the increase in cardiac procedures. Brazil has been spending more on healthcare recently, with increased contributions from the public and private industries. Due to the eagerness of healthcare providers to invest money in top-of-the-line, cutting-edge equipment to enhance patient outcomes, has created a favourable environment for makers of cardiac surgery instruments. a senescent populace, cardiovascular diseases are more common in Brazil. The demand for cardiac surgery instruments is expected to rise as the population gets older.

Market Restraints

The cardiac surgery instrument market in Brazil is highly saturated, with local as well as global manufacturers vying for market share. It might be difficult for manufacturers to distinguish themselves from the competition and maintain a healthy profit margin. In Brazil, where healthcare workers are frequently cost-conscious, there is a high demand for affordably priced healthcare services and products. As a result, it might be challenging for producers of instruments for cardiac surgery to keep high-profit margins.

Competitive Landscape

Key Players

Nipro Medical do Brasil Ltda (BR)
Arthrocare do Brasil Ltda (BR)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Healthcare Policies and Regulatory Landscape

In Brazil, the authority for regulating the licensing of cardiac surgery instruments falls to the Brazilian National Health Surveillance Agency. All facets of the production, sale, and distribution of cardiac surgery instruments in Brazil are governed by ANVISA laws and rules. Technical guidelines are developed and equipment used in cardiac surgery is tested by the National Institute of Metrology, Quality, and Technology. The majority of Brazilians receive state-funded healthcare through the Unified Health System (UHS), which also establishes policies and standards for the delivery of healthcare, including the use of medical devices. Cardiac surgery instruments are among the medical technologies that the National Commission for the Incorporation of Technologies in the Unified Health System reviews to see if they should be included in the Brazilian health system.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The Brazil market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.